Trademark Overview
On Monday, April 8, 2024, a trademark application was filed for ALPHA NK T with the United States Patent and Trademark Office. The USPTO has given the ALPHA NK T trademark a serial number of 98488515. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, April 8, 2024. This trademark is owned by ImmunityBio, Inc.. The ALPHA NK T trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and substances for the treatment of human diseases and animal diseases, namely, cancer, non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, infections, and infectious diseases for clinical, medicinal, therapeutic, vaccine and vaccine adjuvant purposes; pharmaceutical preparations and substances for the prevention of human diseases and animal diseases, namely, cancer, non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, infections, and infectious diseases, for clinical, medicinal, therapeutic, vaccine, and vaccine adjuvant purposes; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human diseases and animal diseases, namely, cancer, and infectious diseases; biological preparations for medical purposes, namely, in the fields of immunotherapy, and immuno-oncology; anti-infectives for medical use for the treatment of human diseases and animal diseases, namely, ...
